Tiny steroid dose may boost RA treatment in new patients
NCT ID NCT07252271
First seen Dec 12, 2025 · Last updated May 16, 2026 · Updated 21 times
Summary
This study tests whether adding a very low dose (4 mg) of the steroid prednisolone to standard rheumatoid arthritis (RA) medications helps control disease better than standard care alone. About 112 adults newly diagnosed with active RA will take either prednisolone or a placebo for 5 weeks, then slowly stop. The goal is to see if this short-term add-on improves symptoms and disease activity scores.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.